ArticleInternational journal of clinical and experimental medicine2015
A rat model of liver transplantation with a steatotic donor liver after cardiac death.
Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- GSK-3β mediates ischemia-reperfusion injury by regulating autophagy in DCD liver allografts.International journal of clinical and experimental pathology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to establish a rat liver transplantation model with a steatotic donor liver after cardiac death, reflecting clinical conditions. Rats were fed a high-fat diet for 8 weeks to establish the fatty liver model. This model simulates liver steatosis caused by various factors before clinical donation after cardiac death. A pneumothorax was created in the donor rat to induce hypoxia and cardiac arrest before incising the liver. This simulated the processes of hypoxia and cardiac arrest caused by withdrawal of treatment in actual clinical situations. The harvested cardiac death donor liver was then transplanted using the Kamada technique. Donor operative time was 45.7 ± 4.2 min; cardiac arrest time, 9 ± 0.8 min; recipient surgery time, 40.3 ± 4.9 min; and no-liver time, 15 ± 2.5 min. Of 40 liver-transplanted rats, 2 died within 24 h, with a surgical success rate of 95%. The transaminase levels on post-transplantation days 1, 3, 5, and 7 were 835.4 ± 71.33 U/L, 1334.5 ± 102.13 U/L, 536.4 ± 65.52 U/L, and 218.2 ± 36.77 U/L, respectively. This rat liver transplantation model with a steatotic donor liver after cardiac death could improve the simulation of the pathophysiological processes of clinical donation after cardiac death, and could be used as a reliable and stable animal model.
Indexed as
Identifiers
26629068PMC4658957W2243918570What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.